PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
[No public or meaningful name is available] 939-657-1 - - - - - 1 - - - - Details
[No public or meaningful name is available] 467-270-3 - - - - - 1 - - - - Details
[No public or meaningful name is available] 943-903-3 - - - - - 1 - - - - Details
[No public or meaningful name is available] 700-674-2 - - - 1 - 1 - - - - Details
[No public or meaningful name is available] 485-180-2 - - - - - 1 - - - - Details
[No public or meaningful name is available] 484-400-4 - - - - - 1 - - - - Details
[No public or meaningful name is available] 470-140-9 - - - - - 1 - - - - Details
[No public or meaningful name is available] - - - - 1 - - - - - - Details
[No public or meaningful name is available] 451-410-5 - - - - - 1 - - - - Details
[No public or meaningful name is available] 442-590-6 - - - - - 1 - - - - Details
[No public or meaningful name is available] 470-070-9 - - - - - 1 - - - - Details
[No public or meaningful name is available] 479-490-7 - - - - - 1 - - - - Details
[No public or meaningful name is available] 464-900-9 - - - - - 1 - - - - Details
[No public or meaningful name is available] 700-518-3 - - - - - 1 - - - - Details
[No public or meaningful name is available] 464-290-4 - - - - - 1 - - - - Details
[No public or meaningful name is available] 460-300-6 - - - - - 1 - - - - Details
[No public or meaningful name is available] 480-150-5 - - - - - 1 - - - - Details
[No public or meaningful name is available] - - - - 1 - 1 - - - - Details
[No public or meaningful name is available] - - - - 1 - - - - - - Details
[No public or meaningful name is available] 452-180-9 - - - - - 1 - - - - Details
[No public or meaningful name is available] 451-180-6 - - - - - 1 - - - - Details
[No public or meaningful name is available] 451-400-0 - - - - - 1 - - - - Details
[No public or meaningful name is available] 451-120-9 - - - - - 1 - - - - Details
[No public or meaningful name is available] 453-150-8 - - - - - 1 - - - - Details
[No public or meaningful name is available] 451-170-1 - - - - - 1 - - - - Details
[No public or meaningful name is available] 451-220-2 - - - - - 1 - - - - Details
[No public or meaningful name is available] 451-110-4 - - - - - 1 - - - - Details
[No public or meaningful name is available] 480-500-7 - - - - - 1 - - - - Details
[No public or meaningful name is available] 480-000-9 - - - - - 1 - - - - Details
[No public or meaningful name is available] 700-380-4 - - - - - 1 - - - - Details
[No public or meaningful name is available] 944-134-6 - - - - - 1 - - - - Details
[No public or meaningful name is available] 931-053-6 - - - 1 - 1 - - - - Details
[No public or meaningful name is available] 939-704-6 - - - 1 - - - - - - Details
[No public or meaningful name is available] 473-680-3 - - - - - 1 - - - - Details
[No public or meaningful name is available] - - - - 1 - 1 - - - - Details
[3-(2-{dimethyl[3-(2-methylprop-2-enamido)propyl]azaniumyl}acetamido)propyl][(2R)-2-hydroxy-3-(trimethylazaniumyl)propyl]dimethylazanium [3-(2-{dimethyl[3-(2-methylprop-2-enamido)propyl]azaniumyl}acetamido)propyl][(2S)-2-hydroxy-3-(trimethylazaniumyl)propyl]dimethylazanium hexachloride 700-055-7 - - - 1 - - - - - - Details
[(2-hydroxyacetyl)oxy](oxo) vanadium 2-hydroxyacetate 947-007-3 - - - - - 1 - - - - Details
9917E 432-690-8 - - - - - 1 - - - - Details
9812E 428-760-2 - - - - - 1 - - - - Details
9-Octadecenoic acid (Z)-, C12-15-alkyl esters 947-849-1 - - - - - 1 - - - - Details
8-dodecen-1-yl acetate - - - - - - - 1 - - - Details
7-amino-3-{(E)-[5-({4-(2-chloroethyl)butanoyl}amino)]diazenyl}-4-hydroxy-8-[(E)-(4-{2-(sulfonatooxy)ethyl}) diazenyl]naphthalene, polysulfonate, polysulfonyl, polyphenyl, sodium/potassium salt - - - - 1 - 1 - - - - Details
6-oxo- 6H‒Dibenz[c, e] [1, 2] oxaphosphorin 6-alkyl derivative - - - - 1 - 1 - - - - Details
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts 701-271-4 - - - - - - 1 - - - Details
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid 701-162-1 - - - - - - 1 - - - Details
6-(3-(3-tert-Butyl-4-hydroxy-5-methylphenyl)propoxy)-2,4,8,1 0-tetra-tert-butyldibenz(d,f)(1,3,2)dioxaphosphepin 442-450-4 - - - 2 - 1 - - - - Details
5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [2]
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
- - - 1 - - - - 1 1 - Details
5-Methoxy-2-tetralone 457-080-9 - - - 1 - - - - - - Details
5-ethylidene-8,9,10-trinorborn-2-ene, manufacture of, by-products from 948-406-5 - - - - - 1 - - - - Details
5-endo-decyl-bicyclo[hept-2-ene / 5-endo/decyl-bicyclo[2.2.1]hept-2-ene 435-040-1 - - - - - 1 - - - - Details

Export search results to: